An Open-Label, Phase 3 Study Examinig the Long-Term Safety, Tolerability and Efficacy of APL-130277 in Levodopa Responsive Patients with Parkinson's Disease Complicated by Motor Fluctuations ("OFF" Episodes)

September 24, 2018
https://clinicaltrials.gov/ct2/show/NCT02542696
Parkinson Disease
Principal Investigator: Peter A Le Witt, MD
Parkinson's, Levodopa
Accepting Participants
(248)661-6540